Clincosm LogoSign in Get a demo

Non-Hodgkin Lymphoma

Showing 51 - 75 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Follicular Lymphoma
  • Little Rock, Arkansas
  • +95 more
Sep 9, 2022

Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • CD19x22 CAR T Cells
  • Aurora, Colorado
    University of Colorado Hospital
Sep 1, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 23, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Aug 19, 2022

Non-hodgkin Lymphoma Trial in United States (MT-3724)

Terminated
Has Results
  • Non-hodgkin Lymphoma
  • Whittier, California
  • +4 more
Jul 18, 2022

Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)

Completed
  • Non-Hodgkin Lymphoma
  • Milano, Italy
    Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022

Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab, Polatuzumab vedotin, Tocilizumab)

Recruiting
  • Non-Hodgkin Lymphoma
  • Buenos Aires, Argentina
  • +18 more
Aug 10, 2022

Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

Recruiting
  • Lung Cancer
  • +8 more
  • Home-based cardiac rehabilitation
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 9, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia Trial in Topeka, Omaha

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Topeka, Kansas
  • +1 more
Aug 4, 2022

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Non-Hodgkin Lymphoma Trial in United States (Mosunetuzumab (Cohorts A-C), Mosunetuzumab (Cohorts D-E), Tocilizumab)

Recruiting
  • Non-Hodgkin Lymphoma
  • Mosunetuzumab (Cohorts A-C)
  • +2 more
  • Anchorage, Alaska
  • +19 more
Jul 25, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

Recruiting
  • B-cell Malignancy, Low-grade
  • +4 more
  • Beijing, Beijing, China
  • +8 more
Jul 20, 2022

Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

Recruiting
  • Non-Hodgkin Lymphoma
  • Focal radiation therapy (RT)
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 8, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)

Recruiting
  • Non-hodgkin Lymphoma
  • Acute Lymphocytic Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 30, 2022

Decision Support System, Non-Hodgkin Lymphoma Trial (The effectiveness of the online decision support system developed for

Not yet recruiting
  • Decision Support System
  • Non-Hodgkin Lymphoma
  • The effectiveness of the online decision support system developed for symptom self-management
  • Symptom self-management with an education booklet
  • (no location specified)
Jul 1, 2022

Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Non-Hodgkin Lymphoma
    • Miami, Florida
    • +7 more
    Jun 23, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

    Recruiting
    • Leukemia, Myeloid, Acute
    • +5 more
    • Melbourne, Victoria, Australia
      Melbourne Health
    Jun 19, 2022

    Blood Clots and Bleeding in Hematological Malignancies, HAT

    Recruiting
    • Acute Leukemia
    • +7 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jun 17, 2022

    Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

    Recruiting
    • Non-hodgkin Lymphoma
    • Hodgkin Lymphoma
    • DOC Group B
    • +16 more
    • Valhalla, New York
      New York Medical College
    Jun 9, 2022

    Non-Hodgkin Lymphoma Trial in BeiJing, Guangzhou, Shanghai (ZN-d5)

    Enrolling by invitation
    • Non-Hodgkin Lymphoma
    • BeiJing, Beijing, China
    • +2 more
    May 9, 2022